Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Leukemia

Free Subscription Articles published in Br J Cancer Retrieve available abstracts of 13 articles: HTML format

Single Articles

February 2023
1. WANG L, Zhang Q, Ye L, Ye X, et al
   All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARalpha-Nrf2 complex.
   Br J Cancer. 2023;128:691-701.
   PubMed     Abstract available
   
   
   November 2022
2. SUNGUC C, Hawkins MM, Winter DL, Dudley IM, et al
   Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
   Br J Cancer. 2022 Nov 1. pii: 10.1038/s41416-022-02016.
   PubMed     Abstract available
   
   
   September 2022
3. VENN NC, Huang L, Hovorkova L, Muskovic W, et al
   Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
   Br J Cancer. 2022;127:908-915.
   PubMed     Abstract available
   
   
   July 2022
4. SELLIN M, Mack R, Rhodes MC, Zhang L, et al
   Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression.
   Br J Cancer. 2022;127:223-236.
   PubMed     Abstract available
   
   
   February 2022
5. JIANG Y, Southam AD, Trova S, Beke F, et al
   Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
   Br J Cancer. 2022;126:275-286.
   PubMed     Abstract available
   
   
   
6. SUBHASH VV, Huang L, Kamili A, Wong M, et al
   Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
   Br J Cancer. 2022;126:482-491.
   PubMed     Abstract available
   
   
   September 2021
7. TARIQ MU, Furqan M, Parveen H, Ullah R, et al
   CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells.
   Br J Cancer. 2021;125:966-974.
   PubMed     Abstract available
   
   
   July 2021
8. MOGENSEN H, Modig K, Talback M, Erdmann F, et al
   Number of siblings and survival from childhood leukaemia: a national register-based cohort study from Sweden.
   Br J Cancer. 2021;125:112-118.
   PubMed     Abstract available
   
   
   
9. KARSA M, Kosciolek A, Bongers A, Mariana A, et al
   Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
   Br J Cancer. 2021;125:55-64.
   PubMed     Abstract available
   
   
   May 2021
10. SONG S, Zhang J, Su Q, Zhang W, et al
    Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
    Br J Cancer. 2021;124:1843-1853.
    PubMed     Abstract available
    
    
    February 2021
11. PINTO-FERNANDEZ A, Salio M, Partridge T, Chen J, et al
    Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Br J Cancer. 2021;124:817-830.
    PubMed     Abstract available
    
    
    January 2021
12. BARROW TM, Nakjang S, Lafta F, Bilotkach K, et al
    Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia.
    Br J Cancer. 2021;124:474-483.
    PubMed     Abstract available
    
    
    December 2020
13. PUETT RC, Poulsen AH, Taj T, Ketzel M, et al
    Relationship of leukaemias with long-term ambient air pollution exposures in the adult Danish population.
    Br J Cancer. 2020;123:1818-1824.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: